Angela Holder

932 total citations
37 papers, 702 citations indexed

About

Angela Holder is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Angela Holder has authored 37 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 26 papers in Virology and 14 papers in Epidemiology. Recurrent topics in Angela Holder's work include HIV/AIDS Research and Interventions (31 papers), HIV Research and Treatment (26 papers) and HIV, Drug Use, Sexual Risk (10 papers). Angela Holder is often cited by papers focused on HIV/AIDS Research and Interventions (31 papers), HIV Research and Treatment (26 papers) and HIV, Drug Use, Sexual Risk (10 papers). Angela Holder collaborates with scholars based in United States, Uganda and Kenya. Angela Holder's co-authors include J. Gerardo Garcı́a-Lerma, Walid Heneine, James Mitchell, Amy Martin, Debra L. Hanson, Zsuzsanna Kuklenyik, Chou-Pong Pau, Chou‐Pong Pau, Jonathan Lipscomb and Qi Zheng and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Angela Holder

35 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Holder United States 13 531 380 206 134 87 37 702
Nicola Richardson‐Harman United States 15 512 1.0× 426 1.1× 240 1.2× 251 1.9× 77 0.9× 26 738
Manjula Gunawardana United States 16 326 0.6× 210 0.6× 145 0.7× 170 1.3× 170 2.0× 29 678
Mackenzie L. Cottrell United States 16 879 1.7× 486 1.3× 367 1.8× 69 0.5× 88 1.0× 78 1.2k
Ae S. Youngpairoj United States 14 650 1.2× 575 1.5× 261 1.3× 36 0.3× 90 1.0× 22 821
Rahul P. Bakshi United States 19 483 0.9× 294 0.8× 257 1.2× 194 1.4× 201 2.3× 42 949
Kailazarid Gomez United States 10 351 0.7× 168 0.4× 182 0.9× 136 1.0× 29 0.3× 12 510
Craig Hoesley United States 12 301 0.6× 108 0.3× 198 1.0× 84 0.6× 67 0.8× 29 620
Brian Louie United States 15 572 1.1× 308 0.8× 405 2.0× 52 0.4× 26 0.3× 19 706
Mar Vera Spain 12 269 0.5× 171 0.5× 133 0.6× 25 0.2× 141 1.6× 29 457
Meropi Aravantinou United States 15 309 0.6× 391 1.0× 197 1.0× 260 1.9× 79 0.9× 26 717

Countries citing papers authored by Angela Holder

Since Specialization
Citations

This map shows the geographic impact of Angela Holder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Holder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Holder more than expected).

Fields of papers citing papers by Angela Holder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Holder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Holder. The network helps show where Angela Holder may publish in the future.

Co-authorship network of co-authors of Angela Holder

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Holder. A scholar is included among the top collaborators of Angela Holder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Holder. Angela Holder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daly, Michele B., Chuong Dinh, Angela Holder, et al.. (2024). SHIV remission in macaques with early treatment initiation and ultra long-lasting antiviral activity. Nature Communications. 15(1). 10550–10550.
2.
Massud, Ivana, Kenji Nishiura, Susan Ruone, et al.. (2024). Weekly Oral Tenofovir Alafenamide Protects Macaques from Vaginal and Rectal Simian HIV Infection. Pharmaceutics. 16(3). 384–384.
3.
Makarova, Natalia, M. Melissa Peet, James Mitchell, et al.. (2023). Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques. The Journal of Infectious Diseases. 229(6). 1791–1795. 2 indexed citations
4.
Dobard, Charles, M. Melissa Peet, Kenji Nishiura, et al.. (2022). Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaques. EBioMedicine. 86. 104361–104361. 11 indexed citations
5.
Gatto, Gregory J., Sai Archana Krovi, Lei Li, et al.. (2022). Comparative Pharmacokinetics and Local Tolerance of Tenofovir Alafenamide (TAF) From Subcutaneous Implant in Rabbits, Dogs, and Macaques. Frontiers in Pharmacology. 13. 923954–923954. 10 indexed citations
6.
Makarova, Natalia, M. Melissa Peet, James Mitchell, et al.. (2022). Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaques. EBioMedicine. 86. 104338–104338. 7 indexed citations
7.
Massud, Ivana, Sai Archana Krovi, Kenji Nishiura, et al.. (2022). Safety and efficacy of a biodegradable implant releasing tenofovir alafenamide for vaginal protection in a macaque model. Journal of Antimicrobial Chemotherapy. 77(11). 2964–2971. 7 indexed citations
8.
Daly, Michele B., Angela Holder, Chuong Dinh, et al.. (2020). The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques. Antiviral Research. 186. 105001–105001. 2 indexed citations
9.
Massud, Ivana, Susan Ruone, María Zlotorzynska, et al.. (2020). Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques. EBioMedicine. 58. 102894–102894. 15 indexed citations
10.
Daly, Michele B., April M. Clayton, Susan Ruone, et al.. (2019). Training rhesus macaques to take daily oral antiretroviral therapy for preclinical evaluation of HIV prevention and treatment strategies. PLoS ONE. 14(11). e0225146–e0225146. 5 indexed citations
11.
McLellan–Lemal, Eleanor, Roman Gvetadze, Yi Pan, et al.. (2018). Non-adherence among women enrolled in a contraceptive vaginal ring use study in Kisumu, Kenya, 2014-2015. SHILAP Revista de lepidopterología. 2. 2 indexed citations
12.
Pereira, Lara, Amy Martin, Chuong Dinh, et al.. (2018). Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques. Drug Delivery and Translational Research. 8(5). 1180–1190. 5 indexed citations
13.
Haaland, Richard E., Jeffrey J. Fountain, Yingtian Hu, et al.. (2018). Repeated rectal application of a hyperosmolar lubricant is associated with microbiota shifts but does not affect PrEP drug concentrations: results from a randomized trial in men who have sex with men. Journal of the International AIDS Society. 21(10). e25199–e25199. 17 indexed citations
14.
Haaland, Richard E., et al.. (2017). Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis. AIDS. 31(11). 1647–1650. 8 indexed citations
15.
Radzio, Jessica, Tara Henning, C E Farshy, et al.. (2016). Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques HarboringChlamydia trachomatisandTrichomonas vaginalis. The Journal of Infectious Diseases. 213(10). 1541–1545. 10 indexed citations
16.
McConville, Christopher, James M. Smith, Clare F. McCoy, et al.. (2015). Lack of in vitro–in vivo correlation for a UC781-releasing vaginal ring in macaques. Drug Delivery and Translational Research. 5(1). 27–37. 12 indexed citations
17.
Dobard, Charles, Sunita Sharma, Mian‐er Cong, et al.. (2015). Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques. Retrovirology. 12(1). 69–69. 11 indexed citations
18.
Radzio, Jessica, Wutyi Aung, Angela Holder, et al.. (2012). Prevention of Vaginal SHIV Transmission in Macaques by a Coitally-Dependent Truvada Regimen. PLoS ONE. 7(12). e50632–e50632. 58 indexed citations
19.
Holder, Angela, et al.. (2009). Facilitating chromophore formation of engineered Ca2+ binding green fluorescent proteins. Archives of Biochemistry and Biophysics. 486(1). 27–34. 7 indexed citations
20.
Kuklenyik, Zsuzsanna, Amy Martin, Chou‐Pong Pau, et al.. (2009). On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors. Journal of Chromatography B. 877(29). 3659–3666. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026